METADX
Latest round
- Seed
Last raised
- Apr 2025
Total raised
- $0.3M
Investors
- 4
About METADX
, Ltd. operates as a pet healthcare solutions company that creates AI solutions for veterinary medicine. MetaDx’s primary offerings include CancerVET™, an AI-based platform designed to detect tumors in pets by analyzing biomarkers in their serum, and VitalVET™, an AI-driven anesthesia monitoring system that predicts anesthesia depth and emergency situations based on real-time vital signs. The company also provides TraceVET™, a referral testing service that streamlines diagnostic testing for veterinarians by handling tests in a central laboratory, ensuring quality results.
Who invested in METADX
4 investors across 3 rounds
See all investors in METADX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about METADX
Who invested in METADX?
METADX has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has METADX raised?
METADX has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did METADX last raise money?
METADX's most recent round on record is a Seed, in Apr 2025.
What does METADX do?
METADX is a biotechnology company.
Where is METADX headquartered?
METADX is headquartered in Seoul, South Korea.
Which VCs invest in companies like METADX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at METADX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like METADX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.